The Pfizer/BioNTech bivalent COVID-19 vaccine (both Original and Omicron BA.4/BA.5) is already FDA-authorized under an EUA for use in individuals 12 years old and above as a single booster dose ...
Pfizer and BioNTech's Covid-19 vaccine for kids should be the topic of discussion when the FDA's vaccine advisory committee meets Tuesday. The companies said that the vaccine was effective at ...
Pfizer submitted initial data from its COVID vaccine trial on kids between the ages of 5 and 11 to the FDA Tuesday, setting up the possibility of wide-spread vaccinations by Halloween. Pfizer ...
“COVID-19 continues to be a very real risk for many people, and we encourage individuals to consider staying current with vaccination, including with a bivalent COVID-19 vaccine,” Marks said.
Opinions expressed by Forbes Contributors are their own. I am a writer, journalist, professor, systems modeler, computational and digital health expert, avocado-eater, and entrepreneur, not always ...
T he COVID vaccine may be linked to a small increase in stroke risk when given with a high-dose flu shot, primarily in ...
Opinions expressed by Forbes Contributors are their own. I am a writer, journalist, professor, systems modeler, computational and digital health expert, avocado-eater, and entrepreneur, not always ...
Aiming to provide additional protection for Americans against the coronavirus over the upcoming flu season, the FDA authorized new versions of Pfizer and Moderna’s Covid-19 vaccines. WASHINGTON (CN) — ...
Last fall, U.S. health officials authorized new COVID-19 booster shots designed to target the original strain of the coronavirus and some of the Omicron subvariants that were circulating around ...
WATCH: Nobel in medicine goes to scientists whose work on mRNA led to COVID vaccine Hungarian-American Katalin Karikó and American Drew Weissman were cited for contributing vaccine development ...
Federal health officials have greenlighted a second shot of the omicron booster for some older adults and those who are immunocompromised. On Wednesday, advisors to the Centers for Disease Control ...
Brazilian drug regulator Anvisa on Monday (Jul. 24) gave its full approval for the bivalent Comirnaty COVID-19 vaccine by Pfizer. The jab is recommended for the prevention of COVID-19 and may now ...